| |
| |
|
| Insider
Information: |
Lebkowski Jane |
| Relationship: |
|
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
671,145 |
|
|
Indirect Shares
|
21,177 |
|
|
| Direct
Value |
$2,074,502 |
|
|
|
Indirect Value
|
$73,696 |
|
|
| Total
Shares |
692,322 |
|
|
| Total
Value |
$2,148,198 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Geron Corporation |
GERN |
SVP, Chief Scientific ... |
2011-06-14 |
568,154 |
2010-01-14 |
21,177 |
Premium* |
|
|
Asterias Biotherapeutics Inc |
AST |
|
2017-06-05 |
102,991 |
2014-08-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
37 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GERN |
Geron Corporation |
SVP Regen Medicine |
• – – |
2008-01-02 |
4 |
A |
$5.73 |
$20,496 |
I/I |
3,577 |
13,693 |
0 |
- |
|
| GERN |
Geron Corporation |
SVP, CSO Regen Med |
• – – |
2010-01-14 |
4 |
A |
$6.22 |
$21,994 |
I/I |
3,536 |
21,177 |
0 |
- |
|
| AST |
Asterias Biotherapeutics ... |
Chief Scientific Officer |
• • – |
2017-06-05 |
4 |
D |
$3.20 |
$22,448 |
D/D |
(7,015) |
102,991 |
0 |
- |
|
| AST |
Asterias Biotherapeutics ... |
President of R&D |
• – – |
2015-09-15 |
4 |
AS |
$6.00 |
$29,472 |
D/D |
(4,912) |
476 |
0 |
- |
|
| GERN |
Geron Corporation |
SVP Regen Medicine |
• – – |
2009-01-05 |
4 |
S |
$4.90 |
$43,419 |
D/D |
(8,861) |
149,906 |
0 |
- |
|
| GERN |
Geron Corporation |
SVP Regen Medicine |
• – – |
2008-01-04 |
4 |
S |
$5.34 |
$47,585 |
D/D |
(8,911) |
147,619 |
0 |
- |
|
| GERN |
Geron Corporation |
SVP, Regenerative Medicine |
• – – |
2005-01-13 |
4 |
S |
$8.57 |
$52,740 |
D/D |
(6,154) |
17,137 |
|
- |
|
| GERN |
Geron Corporation |
SVP Regen Medicine |
• – – |
2008-05-23 |
4 |
D |
$3.92 |
$54,300 |
D/D |
(13,852) |
133,767 |
0 |
- |
|
| GERN |
Geron Corporation |
SVP, CSO Regen Med |
• – – |
2010-06-02 |
4 |
S |
$5.43 |
$57,650 |
D/D |
(10,617) |
196,891 |
0 |
- |
|
| GERN |
Geron Corporation |
officerTitle |
• – – |
2006-01-09 |
4 |
S |
$8.56 |
$91,387 |
D/D |
(10,676) |
19,254 |
|
- |
|
| GERN |
Geron Corporation |
SVP, CSO Regen Med |
• – – |
2009-05-26 |
4 |
S |
$6.75 |
$95,121 |
D/D |
(14,092) |
122,121 |
0 |
- |
|
| GERN |
Geron Corporation |
SVP, Chief Scientific Officer |
• – – |
2011-06-14 |
4 |
S |
$4.28 |
$108,121 |
D/D |
(25,262) |
568,154 |
0 |
- |
|
37 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
